Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Feb 10:12:37.
doi: 10.1186/1745-6215-12-37.

A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial

W D van Dijk  1 , P T J Scheepers, R Cremers, J W M Lenders, W Klerx, C van Weel, T R J Schermer, Y Heijdra
Affiliations
Randomized Controlled Trial

A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial

W D van Dijk et al. Trials. .

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a common disease, associated with cardiovascular disease. Many patients use (long-acting) bronchodilators, whilst they continue smoking alongside. We hypothesised an interaction between bronchodilators and smoking that enhances smoke exposure, and hence cardiovascular disease. In this paper, we report our study protocol that explores the fundamental interaction, i.e. smoke retention.

Method: The design consists of a double-blinded, placebo-controlled, randomised crossover trial, in which 40 COPD patients smoke cigarettes during both undilated and maximal bronchodilated conditions. Our primary outcome is the retention of cigarette smoke, expressed as tar and nicotine weight. The inhaled tar weights are calculated from the correlated extracted nicotine weights in cigarette filters, whereas the exhaled weights are collected on Cambridge filters. We established the inhaled weight calculations by a pilot study, that included paired measurements from several smoking regimes. Our study protocol is approved by the local accredited medical review ethics committee.

Discussion: Our study is currently in progress. The pilot study revealed valid equations for inhaled tar and nicotine, with an R2 of 0.82 and 0.74 (p < 0.01), respectively. We developed a method to study pulmonary smoke retentions in COPD patients under the influence of bronchodilation which may affect smoking-related disease. This trial will provide fundamental knowledge about the (cardiovascular) safety of bronchodilators in patients with COPD who persist in their habit of cigarette smoking.

Trial registration: ClinicalTrials.gov: NCT00981851.

PubMed Disclaimer

Figures

Figure 1
Figure 1
20% increase (---) of a normal inhalation volume (--) leads to a mean 5% increase in retention (*) of 3 main tar compounds.
Figure 2
Figure 2
Correlation between cigarette and Cambridge filter nicotine (Pearson's correlation coefficient of 0.90).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:549–555. doi: 10.1513/pats.200709-148ET. - DOI - PMC - PubMed
    1. Curkendall SM, Lanes S, de Luise C, Stang MR, She D, Goehring E Jr. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol. 2006;21:803–813. doi: 10.1007/s10654-006-9066-1. - DOI - PubMed
    1. GOLD executive committee, GOLD science committee. GOLD Guidelines 2009. 2010. http://www.goldcopd.com
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519. doi: 10.1136/bmj.38142.554479.AE. - DOI - PMC - PubMed
    1. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S. Interheart Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647–658. doi: 10.1016/S0140-6736(06)69249-0. - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data